Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study
Update: 2024-12-18
Description
Not every drug that has reached human clinical trials has needed preliminary nonclinical studies to demonstrate safety. This podcast episode is a case study for replacing the use of animals during the safety testing that occurs prior to human clinical trials, in which our guest speaker reviews conversations with regulatory authorities regarding a modern nonanimal testing strategy utilized to bring a nonequine-derived antitoxin as a therapeutic product to a patient.
Comments
In Channel




